Introduction


Dinesh Vijan’s horror-comedy universe continues to entertain audiences with its latest release, Thama.


The film stars ayushmann khurrana and rashmika mandanna in lead roles, along with nawazuddin siddiqui and paresh rawal in pivotal parts.


Directed by Aditya Sarpotdar and produced by amar kaushik and Dinesh Vijan, the film has received mixed reviews but a strong audience turnout.


Fifth-Day Surge in Collections


According to a report by Sacnilk, Thama showed a strong upward trend on its fifth day (Saturday).


The film reportedly collected ₹13 crore on its fifth day.


With this surge, the total domestic collection has reached approximately ₹78.60 crore.


The increase in footfalls over the weekend suggests positive word-of-mouth and strong family audience appeal.


Day-Wise box office Collection


Day 1 (Opening Day): ₹24 crore (₹23.75 crore in hindi + ₹0.25 crore in Telugu)


Day 2: ₹18.6 crore


Day 3: ₹13 crore


Day 4: ₹10 crore


Day 5: ₹13 crore (estimated)


Total (5 Days): ₹78.60 crore (approx.)


Ayushmann Khurrana’s Career Milestone


With its strong performance, Thama has become Ayushmann Khurrana’s fifth-highest-grossing film.


It has surpassed several of his notable hits, including:


Andhadhun – ₹74.32 crore


Article 15 – ₹66 crore


Shubh Mangal Zyada Saavdhan – ₹62 crore


Shubh Mangal Saavdhan – ₹42 crore


Vicky Donor – ₹35.32 crore



If the current momentum continues, Thama may soon surpass bala and dream girl 2 in total collections.


Rashmika Mandanna’s box office Growth


For rashmika mandanna, Thama marks her sixth-highest-grossing film.


It has overtaken:


Sita Ramam – ₹8.23 crore


Varisu – ₹6.82 crore


Goodbye – ₹6.82 crore


Kubera – ₹2.17 crore



The film may soon challenge the numbers of her blockbuster Pushpa: The Rise (₹106.35 crore).


Conclusion


With strong weekend momentum and growing audience appreciation, Thama is shaping up to be a commercial success.


The film’s blend of horror, humor, and heart seems to have connected well with moviegoers, promising an impressive lifetime run.


Disclaimer:

The information contained in this article is for general informational purposes only. While we strive to ensure accuracy, we make no warranties or representations of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the content. Any reliance you place on the information is strictly at your own risk. The views, opinions, or claims expressed in this article are those of the author and do not necessarily reflect the official policy or position of any organization mentioned. We disclaim any liability for any loss or damage arising directly or indirectly from the use of this article.

Find out more: